Story · Medicine & Biotech

Personalized therapies for Crohn's and ulcerative colitis may follow from method that identifies harmful gut bacteria

1 outlet · first reported by Medical Xpress on

Which gut bacteria contribute to the development or worsening of chronic inflammation? An international research team led by Dr. Lukas Mager from University Hospital Tübingen and Prof. Kathy McCoy from the University of Calgary has developed an approach to identify and selectively target such… (Medical Xpress)

Coverage, in order

  1. Medical Xpress indie
    Personalized therapies for Crohn's and ulcerative colitis may follow from method that identifies harmful gut bacteria

    Which gut bacteria contribute to the development or worsening of chronic inflammation? An international research team led by Dr. Lukas Mager from University Hospital Tübingen and Prof. Kathy McCoy from the University of Calgary has developed an approach to identify and selectively target such…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.